Lithium Carbonate
Lithium carbonate is a mood-stabilizing medication used to treat and prevent manic episodes in bipolar disorder.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 54 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Lithium toxicity is a serious risk — and it can happen even at doses that are supposed to be therapeutic. The level of lithium that causes harm is dangerously close to the level that helps. Before you start lithium, your prescriber needs access to reliable, timely lithium blood-level testing. Watch for warning signs like tremor, confusion, muscle twitching, or slurred speech — and get medical help immediately if they occur. Do not miss your scheduled blood tests.
📖 Lithium Carbonate: Patient Information Guide
A plain-language walkthrough of Lithium Carbonate — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Lithium carbonate is a mood-stabilizing medication approved for the following uses across its supported formulations:
- Treatment of acute manic episodes in bipolar disorder (adults and, for certain formulations, patients 7 years and older)
- Maintenance treatment of bipolar disorder — to reduce how often manic episodes happen and how severe they are when they do
- One formulation is specifically approved as monotherapy (used alone) for bipolar I disorder, including both acute manic or mixed episodes and maintenance treatment, in patients 7 years and older
- Lithobid extended-release tablets are indicated for acute mania and long-term control in adults
⚙️How it works▾
The exact way lithium stabilizes mood is not fully understood. What is known is that it acts as a mood-stabilizing agent in the brain — but scientists have not yet identified the precise mechanism. After you swallow it, lithium is completely absorbed and distributes throughout the body's water. It is not broken down or metabolized at all; your kidneys filter it out unchanged. Because the kidneys handle lithium in a way similar to sodium (salt), changes in your hydration or salt levels directly affect how much lithium stays in your body — which is why diet and fluid balance matter so much with this drug.
💊How it's taken▾
Lithium carbonate is taken by mouth in capsule or tablet form, usually two to three times daily depending on the specific product and your prescriber's instructions. Extended-release formulations are typically dosed less frequently than immediate-release forms.
- Always take it exactly as prescribed — dose is carefully adjusted based on regular blood level tests
- Lithobid extended-release tablets are taken twice daily during both acute treatment and long-term maintenance, as directed
- If you miss a dose, follow your prescriber's or pharmacist's guidance — never double up without instruction
- Blood lithium levels are checked frequently at first (twice a week during the acute phase) and at least every two months during stable long-term treatment
🤒Side effects — in detail▾
Some side effects are common when starting lithium, while others are signs of a more serious problem:
- Fine hand tremor
- Increased thirst and urination
- Nausea, stomach discomfort, or diarrhea — especially early in treatment
- Dizziness and fatigue
- Weight changes or ankle swelling
- Metallic or salty taste in the mouth
- In children (ages 7–17): nausea/vomiting, tremor, dizziness, rash, unsteady gait, decreased appetite, and blurry vision were among the most commonly reported effects
Seek immediate medical help if you develop confusion, slurred speech, severe tremor, muscle twitching, seizures, or loss of consciousness — these are signs of lithium toxicity and require urgent care.
⚠️Warnings & precautions▾
- Lithium toxicity: The toxic level is very close to the therapeutic level. Early signs include tremor, lightheadedness, and weakness. Severe toxicity can cause seizures, coma, and death. Blood tests to monitor your lithium level are essential throughout treatment.
- Dehydration and low sodium: Illness with fever, sweating, vomiting, or diarrhea can raise lithium to dangerous levels. Maintain normal salt intake and stay well hydrated.
- Kidney damage: Long-term lithium use can cause chronic kidney disease. Kidney function is monitored regularly during treatment.
- Thyroid problems: Lithium can cause an underactive or, less commonly, overactive thyroid. Thyroid function is checked before and during treatment.
- Serotonin syndrome: Combining lithium with certain antidepressants or other serotonergic drugs can trigger a potentially life-threatening reaction with agitation, rapid heart rate, and muscle stiffness.
- Brugada syndrome: Lithium has been linked to unmasking a heart rhythm disorder that can cause sudden death. Tell your doctor if you have unexplained fainting or a family history of sudden unexplained death.
- Brain syndrome: Combining lithium with antipsychotic medications has been linked to a serious neurological syndrome, including a risk of irreversible brain damage.
- Elevated calcium: Long-term use can raise blood calcium levels and affect the parathyroid glands.
🔀What it interacts with▾
Many common medications and health conditions can affect how much lithium stays in your body — raising it to toxic levels or lowering it so it stops working:
- Diuretics (water pills): Can reduce lithium clearance and raise blood levels dangerously
- NSAIDs (ibuprofen, naproxen): Reduce lithium excretion, increasing toxicity risk
- ACE inhibitors and ARBs (lisinopril, valsartan): Raise steady-state lithium levels
- Serotonergic drugs (SSRIs, SNRIs, MAOIs, tramadol, triptans, St. John's Wort): Increase risk of serotonin syndrome
- Antipsychotic medications: Combined use raises risk of serious neurological reactions
- Metronidazole (antibiotic): Can increase lithium levels by reducing kidney clearance
- Calcium channel blockers (verapamil, diltiazem): May worsen nervous system side effects
- Iodide preparations: Can worsen lithium-induced hypothyroidism
- Theophylline, acetazolamide, sodium bicarbonate: Can lower lithium levels by increasing how fast the kidneys clear it
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Kidney disease: Lithium is cleared entirely by the kidneys; severe kidney impairment makes it very dangerous to use. Even mild-to-moderate kidney impairment requires lower starting doses and close monitoring.
- Pregnancy: Lithium may cause harm to the baby, including possible heart defects. If you are pregnant or planning to become pregnant, discuss the risks and benefits carefully with your prescriber.
- Breastfeeding: Lithium passes into breast milk at significant levels and is not recommended during breastfeeding. If you choose to breastfeed, your infant must be monitored closely for toxicity signs.
- Children: Safety and effectiveness have been established only in patients 7 years and older for certain formulations; lithium has not been established as safe in children under 7 with bipolar I disorder.
- Older adults: Kidney function naturally declines with age, raising the risk of toxicity. Dose selection should be conservative and kidney function monitored.
- Heart conditions: Lithium should be avoided in patients with Brugada syndrome. Tell your doctor about any heart rhythm problems or history of unexplained fainting.
- Thyroid or calcium problems: Tell your doctor about any existing thyroid or parathyroid conditions before starting lithium.
- Allergy to inactive ingredients: Lithium carbonate is contraindicated if you have a known allergy to any inactive ingredient in the capsule or tablet formulation.
🚑If you take too much▾
Lithium levels above the therapeutic range can cause serious harm, and at very high levels can lead to seizures, coma, and irreversible brain damage. There is no specific antidote for lithium poisoning. If you suspect an overdose or toxic reaction, call the National Poison Control Center at 1-800-222-1222 immediately or go to the nearest emergency room. Hemodialysis (a machine that filters the blood) is the preferred treatment for severe lithium toxicity.
🔬Pharmacokinetics — how your body processes it▾
After you take lithium carbonate by mouth, it is completely absorbed in the upper digestive tract. Immediate-release capsules and tablets reach peak blood levels within about 15 minutes to 3 hours; extended-release preparations take 2 to 6 hours to reach peak levels. Lithium spreads throughout the body's water and binds very little to proteins in the blood. It is not metabolized at all — the liver does not process it. Instead, the kidneys filter it out and excrete it in urine, with a half-life of approximately 18 to 36 hours (meaning it takes that long for half of it to leave your body). In children, how quickly the body clears lithium increases with body weight, so smaller children require lower doses to reach comparable blood levels.
📦How to store it▾
Store and Dispense Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Dispense in a tight, child-resistant container as defined in the USP/NF. Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
📄 Written from Lithium Carbonate’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Lithium Carbonate — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly does lithium do — is it like a sedative? ▾
Why do I need blood tests so often? Can't my doctor just judge by how I feel? ▾
What should I do if I get sick with a fever, vomiting, or diarrhea while on lithium? ▾
Are the side effects I'm feeling at the start going to go away? ▾
I've heard lithium can affect the kidneys and thyroid. Should I be worried? ▾
Is it safe to take ibuprofen or other over-the-counter pain relievers while on lithium? ▾
Is Lithium Carbonate available over the counter? ▾
When was Lithium Carbonate first available? ▾
Who makes Lithium Carbonate? ▾
💬 Answers drafted from Lithium Carbonate’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Lithium Carbonate comes
Lithium Carbonate is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Capsule
How this form is used
- Lithium Carbonate capsules are used to treat acute manic episodes of bipolar disorder
- Lithium Carbonate capsules are used for maintenance treatment of bipolar disorder to reduce frequency and severity of manic episodes
- Lithium Carbonate capsules are approved for these uses in patients 7 years and older as monotherapy for bipolar I disorder
- Lithium Carbonate capsules are taken by mouth, typically multiple times daily as directed by your prescriber
- Blood lithium levels must be monitored regularly throughout treatment
- Follow your prescriber's instructions carefully — dose is adjusted based on your blood levels and clinical response
Extended-release tablet
How this form is used
- Lithium Carbonate extended-release tablets are used to treat manic episodes of bipolar disorder
- Lithium Carbonate extended-release tablets are used for maintenance treatment of bipolar disorder
- Lithobid extended-release tablets are used to treat acute mania and for long-term control of bipolar disorder
- Lithobid extended-release tablets are taken by mouth, generally twice daily during acute mania and long-term maintenance, as directed by your prescriber
- Lithobid tablets should be taken consistently and blood lithium levels must be checked regularly — twice weekly during acute treatment
- Geriatric patients using Lithobid may require lower doses and should be monitored closely for signs of toxicity
- Lithium Carbonate extended-release tablets are taken as directed by your prescriber; do not crush or chew extended-release tablets unless instructed
Tablet
How this form is used
- Lithium Carbonate tablets are used to treat manic episodes of bipolar disorder
- Lithium Carbonate tablets are used for maintenance treatment to prevent or reduce the intensity of future manic episodes
- Lithium Carbonate tablets are taken by mouth as directed by your prescriber
- Regular monitoring of blood lithium levels is required throughout treatment
- Dose is individualized based on blood levels and how you respond clinically
Other oral form
📊 Lithium Carbonate across the U.S. market
How Lithium Carbonate appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (8) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Lithium Carbonate is used
A general measure of how commonly Lithium Carbonate is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Lithium Carbonate is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Lithium Carbonate prescribed? Of the 1,596 medications we measure, Lithium Carbonate ranks #164 by Medicaid prescriptions — more than 90% of them.
Utilization by Lithium Carbonate product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
lithium carbonate 300 MG Oral Capsule Most dispensed
Summed across the 8 of 51 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197889
lithium carbonate 300 MG Extended Release Oral Tablet
Summed across the 8 of 41 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197891
lithium carbonate 450 MG Extended Release Oral Tablet
Summed across the 4 of 19 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197892
lithium carbonate 150 MG Oral Capsule
Summed across the 5 of 32 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311355
lithium carbonate 300 MG Oral Tablet
Summed across the 5 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197890
lithium carbonate 600 MG Oral Capsule
Summed across the 4 of 25 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197893
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Lithium Carbonate, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 34 of 179 listed Lithium Carbonate NDCs with Medicaid activity.
🔍 Compare Lithium Carbonate products
A representative set of FDA-listed product records for Lithium Carbonate — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 300 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | A-S Medication Solutions × 3 listings | NDA | Find on DailyMed ↗ |
| 150 mg | Oral | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 600 mg | Oral | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 600 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 600 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 300 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 150 mg | Oral | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | ANDA | View NDC → |
| 300 mg | Oral | Bryant Ranch Prepack × 10 listings | ANDA | View NDC → |
| 150 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 600 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Cardinal Health | NDA | View NDC → |
| 300 mg | Oral | Cardinal Health 107, LLC × 2 listings | NDA | View NDC → |
| 300 mg | Oral | Clinical Solutions Wholesale | ANDA | View NDC → |
| 150 mg | Oral | Coupler LLC × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 600 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 150 mg | Oral | Hikma Pharmaceuticals USA Inc. × 5 listings | NDA | View NDC → |
| 300 mg | Oral | Hikma Pharmaceuticals USA Inc. × 5 listings | NDA | View NDC → |
| 600 mg | Oral | Hikma Pharmaceuticals USA Inc. × 4 listings | NDA | View NDC → |
| 300 mg | Oral | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | View NDC → |
| 300 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | NuCare Pharmaceuticals,Inc. | ANDA | View NDC → |
| 300 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 600 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 300 mg | Oral | Preferred Pharmaceuticals, Inc. | ANDA | Find on DailyMed ↗ |
| 300 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 150 mg | Oral | Remedyrepack Inc. × 4 listings | ANDA | View NDC → |
| 150 mg | Oral | Remedyrepack Inc. × 4 listings | NDA | View NDC → |
| 300 mg | Oral | Remedyrepack Inc. × 9 listings | ANDA | View NDC → |
| 600 mg | Oral | Remedyrepack Inc. × 4 listings | ANDA | View NDC → |
| 600 mg | Oral | Remedyrepack Inc. × 3 listings | NDA | View NDC → |
| 💊Extended-release tablet | ||||
| 300 mg | Oral | A-S Medication Solutions × 5 listings | ANDA | View NDC → |
| 450 mg | Oral | A-S Medication Solutions | ANDA | Find on DailyMed ↗ |
| 300 mg | Oral | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 450 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 300 mg | Oral | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 300 mg | Oral | Bryant Ranch Prepack | ANDA | Find on DailyMed ↗ |
| 300 mg | Oral | Bryant Ranch Prepack × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 300 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 300 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 450 mg | Oral | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Mylan Institutional Inc. | ANDA | View NDC → |
| 450 mg | Oral | Mylan Institutional Inc. | ANDA | View NDC → |
| 300 mg | Oral | Mylan Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 450 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 300 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 5 listings | ANDA | View NDC → |
| 450 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Proficient Rx LP | NDA AUTHORIZED GENERIC | View NDC → |
| 300 mg | Oral | Remedyrepack Inc. × 7 listings | ANDA | View NDC → |
| 450 mg | Oral | Remedyrepack Inc. × 4 listings | ANDA | View NDC → |
| 300 mg | Oral | Rising Pharmaceuticals, Inc. | ANDA | View NDC → |
| 450 mg | Oral | Rising Pharmaceuticals, Inc. | ANDA | View NDC → |
| 300 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 450 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 💊Other oral form | ||||
| 30 [hp_C]/30 [hp_C] | Oral | Boiron × 2 listings | UNAPPROVED HOMEOPATHIC | View NDC → |
| 200 [kp_C]/200 [kp_C] | Oral | Boiron × 2 listings | UNAPPROVED HOMEOPATHIC | View NDC → |
| 30 [hp_C]/mL | Oral | Natural Health Supply | UNAPPROVED HOMEOPATHIC | View NDC → |
| 30 [hp_C] | Oral | Washington Homeopathic Products | UNAPPROVED HOMEOPATHIC | View NDC → |
| 💊Tablet | ||||
| 450 mg | Oral | AvKARE × 3 listings | ANDA | View NDC → |
| 450 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 450 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 450 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Hikma Pharmaceuticals USA Inc. × 5 listings | NDA | View NDC → |
| 300 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 300 mg | Oral | Remedyrepack Inc. × 3 listings | NDA | View NDC → |
| 300 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 450 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 300 mg | Oral | Sun Pharmaceutical Industries, Inc. × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Albemarle Corporation | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Alivus Life Sciences Limited | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | Emnar Pharma Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Honour Lab Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Livent Usa Corp. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Maithri Drugs Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Novartis Pharmaceuticals Corporation | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Unique Chemicals | BULK INGREDIENT | View NDC → |
Showing 200 of 203 products — FDA National Drug Code Directory. See every product, package size and price: browse all 203 Lithium Carbonate NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Lithium Carbonate — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Lithium Carbonate in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Lithium Carbonate went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 42351 3 dose forms · 9 strengths
-
Dose form (SCDF) Extended Release Oral Tablet RxCUI 372618In current FDA listings -
Dose form (SCDF) Oral Capsule RxCUI 372616In current FDA listings -
Dose form (SCDF) Oral Tablet RxCUI 372617In current FDA listings
Look up RxCUI 42351 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Lithium Carbonate is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 54 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Hikma Pharmaceuticals USA Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.